國家衛生研究院 NHRI:Item 3990099045/15018

NHRI > National Institute of Infectious Diseases and Vaccinology > Chun-Hong Chen > Periodical Articles > Item 3990099045/15018

Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/15018

Title:	Comparing the performance of dengue virus IgG and IgG-capture enzyme-linked immunosorbent assays in seroprevalence study
Authors:	Tsai, JJ;Tsai, CY;Lin, PC;Chen, CH;Tsai, WY;Dai, YC;Lin, YC;Pedroso, C;Brites, C;Wang, WK
Contributors:	National Institute of Infectious Diseases and Vaccinology;National Mosquito-Borne Diseases Control Research Center
Abstract:	Background: Dengue virus (DENV) is the leading cause of arboviral diseases in humans worldwide. Currently Dengvaxia, the first dengue vaccine licensed in 20 countries, was recommended for DENV seropositive individuals aged 9–45 years. Studying dengue seroprevalence can improve our understanding of the epidemiology and transmission dynamics of DENV, and facilitate future intervention strategies and assessment of vaccine efficacy. Several DENV envelope protein-based serological tests including IgG and IgG-capture enzyme-linked immunosorbent assays (ELISAs) have been employed in seroprevalence studies. Previously DENV IgG-capture ELISA was reported to distinguish primary and secondary DENV infections during early convalescence, however, its performance over time and in seroprevalence study remains understudied. Methods: In this study, we used well-documented neutralization test- or reverse-transcription-polymerase-chain reaction-confirmed serum/plasma samples including DENV-naïve, primary and secondary DENV, primary West Nile virus, primary Zika virus, and Zika with previous DENV infection panels to compare the performance of three ELISAs. Results: The sensitivity of the InBios IgG ELISA was higher than that of InBios IgG-capture and SD IgG-capture ELISAs. The sensitivity of IgG-capture ELISAs was higher for secondary than primary DENV infection panel. Within the secondary DENV infection panel, the sensitivity of InBios IgG-capture ELISA decreased from 77.8% at < 6 months to 41.7% at 1–1.5 years, 28.6% at 2–15 years and 0% at > 20 years (p < 0.001, Cochran-Armitage test for trend), whereas that of IgG ELISA remains 100%. A similar trend was observed for SD IgG-capture ELISA. Conclusions: Our findings demonstrate higher sensitivity of DENV IgG ELISA than IgG-capture ELISA in seroprevalence study and interpretation of DENV IgG-capture ELISA should take sampling time and primary or secondary DENV infection into consideration.
Date:	2023-05-08
Relation:	BMC Infectious Diseases. 2023 May 08;23:Article number 301.
Link to:	http://dx.doi.org/10.1186/s12879-023-08307-8
JIF/Ranking 2023:	http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=1471-2334&DestApp=IC2JCR
Cited Times(WOS):	https://www.webofscience.com/wos/woscc/full-record/WOS:000984746200002
Cited Times(Scopus):	https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85158162438
Appears in Collections:	[Chun-Hong Chen] Periodical Articles [Others] Periodical Articles

Files in This Item:

File	Description	Size	Format
SCP85158162438.pdf		1469Kb	Adobe PDF	121	View/Open

Loading...